Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Gentler combo could rival chemo for tough blood cancer

NCT ID NCT04801797

First seen Nov 15, 2025 · Last updated May 24, 2026 · Updated 26 times

Summary

This study tests whether a combination of two drugs, venetoclax and azacitidine, works as well as or better than standard chemotherapy for adults newly diagnosed with acute myeloid leukemia (AML). About 172 participants will be randomly assigned to receive either the new combo or standard chemo. The main goal is to see which approach helps patients live longer without the cancer getting worse or coming back.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE MYELOID LEUKEMIA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Atrium Health Levine Cancer Institute

    Charlotte, North Carolina, 28204, United States

  • Beth Israel Deaconess Medical Center

    Boston, Massachusetts, 02215, United States

  • City of Hope

    Duarte, California, 91010, United States

  • Dana-Farber Cancer Institute

    Boston, Massachusetts, 02215, United States

  • Massachusetts General Hospital Cancer Center

    Boston, Massachusetts, 02114, United States

  • Ohio State University Medical Center

    Columbus, Ohio, 43210, United States

  • Stanford Cancer Center

    Palo Alto, California, 94304, United States

  • University of California - Davis

    Sacramento, California, 95817, United States

  • University of Pennsylvania

    Philadelphia, Pennsylvania, 19104, United States

Conditions

Explore the condition pages connected to this study.